Jeffrey Poole, MD
Gastroenterology · Ogden, UTNPI 1649266776
Payments from drug & device makers
Across 488 payments — averaging $27.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$7K
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Pfizer$603
- Johnson & Johnson$454
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$233
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,807100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 2 | $6,700 |
| AbbVie(2 entities) | 206 | $2,750 |
| Takeda Pharmaceuticals U.S.A., Inc. | 84 | $1,266 |
| Pfizer | 49 | $603 |
| Johnson & Johnson | 39 | $454 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $233 |
| Braintree Laboratories, Inc. | 8 | $150 |
| Sanofi | 10 | $149 |
| Merck | 10 | $146 |
| QOL Medical, LLC | 6 | $138 |
| Organon | 12 | $128 |
| Bristol Myers Squibb | 6 | $96 |
| Phathom Pharmaceuticals, Inc. | 5 | $81 |
| Gilead | 5 | $71 |
| Redhill Biopharma Inc. | 3 | $62 |
| Boehringer Ingelheim | 3 | $61 |
| Intercept Pharmaceuticals, Inc. | 4 | $59 |
| Ardelyx, Inc. | 3 | $49 |
| Echosens North America, Inc. | 1 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $28 |
| Capsovision, Inc. | 1 | $25 |
| Biocon Biologics Inc | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Pharmacosmos Therapeutics Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Acacia Pharma Inc | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Ambu Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Dentsply IH AB | 1 | $14 |
| Amgen | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $12 |
| Shionogi Inc | 1 | $11 |
How this compares
$13,506 in reported general payments places this provider in the 80th percentile of 122 gastroenterology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf)Adalimumab | 12 | $77,755 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 305 | $52,610 |
| MovantikNaloxegol Oxalate | 47 | $20,645 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 94 | $15,350 |
| LinzessLinaclotide | 18 | $13,538 |
| ZenpepLipase/Protease/Amylase | 11 | $13,190 |
| Mesalamine | 12 | $9,962 |
| Sucralfate | 201 | $6,439 |
| Pantoprazole Sodium | 532 | $5,950 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 74 | $5,133 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 32 | $3,997 |
| Omeprazole | 170 | $3,735 |
| Ursodiol | 18 | $2,002 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 115 | $1,912 |
| CholestyramineCholestyramine (With Sugar) | 11 | $1,016 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieHumira(Cf), Linzess | $2,750 | $91,29230 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $28 | $52,610305 claims |
| Redhill Biopharma Inc.Movantik | $62 | $20,64547 claims |
| Braintree Laboratories, Inc.Sutab, Suflave | $150 | $19,347126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 122 gastroenterology providers in Utah.
Other gastroenterology in Ogden
- John LoweOgden$3.6M
- Chad GonzalesOgden$2.9M
- Kyle EliasonOgden$128K
- Eric EliasonOgden$18K
- Joshua VandersteenOgden$7K
- Samuel FrostOgden$4K
- John ValentineSalt Lake City$2.2M
- James TrotterMurray$2M
- Kathryn PetersonSalt Lake City$1.3M
- Priyanka KanthSalt Lake City$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.